7 March 2019 in American Journal of Neuroradiology
BACKGROUND AND PURPOSE: Parenchymal hemorrhage is a severe complication following mechanical recanalization in patients with acute ischemic stroke with large-vessel occlusion. This study aimed to assess whether the metallic hyperdensity sign on noncontrast CT performed immediately after mechanical thrombectomy can predict parenchymal hemorrhage at 24 hours. MATERIALS AND METHODS: We included consecutive patients with acute ischemic stroke with large-vessel occlusion who underwent noncontrast CT immediately after mechanical thrombectomy between January 2014 and September 2018. The metallic hyperdensity sign was defined as a nonpetechial intracerebral hyperdense lesion (diameter, ≥1 cm) in the basal ganglia and a maximum CT density of >90 HU. The sensitivity, specificity, and positive and negative predictive values of the metallic hyperdensity sign in predicting parenchymal hemorrhage were calculated. RESULTS: A total of 198 patients were included. The metallic hyperdensity sign was found in 59 (29.7%) patients, and 51 (25.7%) patients had parenchymal hemorrhage at 24 hours. Patients with the metallic hyperdensity sign are more likely to have parenchymal hemorrhage than those without it (76.3% versus 4.3%, P < .001). The sensitivity, specificity, positive predictive value, and negative predictive value of the metallic hyperdensity sign in predicting parenchymal hemorrhage were 88.2%, 90.5%, 76.3%, and 95.7%, respectively. CONCLUSIONS: The presence of the metallic hyperdensity sign on noncontrast CT performed immediately after mechanical thrombectomy in patients with large-vessel occlusion could predict the occurrence of parenchymal hemorrhage at 24 hours, which might be helpful in postinterventional management within 24 hours after mechanical thrombectomy.
5 April 2018 in American Journal of Neuroradiology
It is still poorly understood about the dynamic changes of the thrombus after intravenous thrombolysis and how the remaining thrombus affects clinical outcome in human stroke. Collateral flow was assumed to help to deliver endo/exogenous tissue-type plasminogen activator to the clot. We aimed to analyze the impact of collateral flow on the dynamic changes of the thrombus in patients with acute large-artery occlusion who received intravenous thrombolysis. We reviewed consecutive patients with acute ischemic stroke with M1 segment or distal internal carotid artery occlusion who underwent multimodal MR imaging or CT perfusion before and 24 hours after intravenous thrombolysis without recanalization. Patients were divided into 3 groups (thrombus extension, shortening, and no change) according to thrombus-length change between baseline and 24 hours. Collateral flow was measured with arrival time delay and the collateral scoring system. Poor outcome was defined as a 3-month modified Rankin Scale score of ≥3. Among 51 patients, 18 (35.3%) had thrombus extension, 14 (27%) had thrombus shortening, and 19 (37.3%) had thrombus without change. Arrival time delay was independently associated with thrombus extension (OR = 1.499; 95% CI, 1.053-2.135; P = .025). Similarly, the collateral score on the peak artery phase was independently associated with thrombus extension (OR = 0.456; 95% CI, 0.211-0.984; P = .045), whereas baseline National Institutes of Health Stroke Scale score (OR = 0.768; 95% CI, 0.614-0.961; P = .021) and baseline thrombus length (OR = 1.193; 95% CI, 1.021-1.394; P = .026) were associated with thrombus shortening. All patients with thrombus extension had poor outcomes. Slow collateral flow was related to thrombus extension in patients with large-artery occlusion without recanalization after intravenous thrombolysis.
31 October 2025 in Reviews in Cardiovascular Medicine
Background: This study aimed to examine the prognostic value of pericoronary adipose tissue (PCAT) attenuation at three months after transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis (AS) and obstructive coronary artery disease (CAD). Methods: This retrospective study included 226 patients with both obstructive CAD and AS who underwent TAVR. PCAT attenuation was measured three months post-TAVR using coronary computed tomography angiogram (CCTA) images. Univariable and multivariable Cox regression analyses were conducted to evaluate the association between PCAT attenuation and major adverse cardiac events (MACEs). Results: Of the 226 patients, 37 experienced MACEs during a median follow-up period of 1.5 years. High PCAT attenuation was significantly associated with MACEs (–65.3 Hounsfield units (HU) vs. –71.6 HU; p < 0.01). The optimal PCAT attenuation threshold of –67.5 HU, determined by receiver operating characteristic (ROC) curve analysis, showed 84% sensitivity and 75% specificity (area under the curve (AUC) = 0.88) for predicting MACEs. Multivariable Cox regression confirmed that higher PCAT attenuation was independently associated with an increased risk of MACEs (hazard ratio (HR) = 1.83, 95% confidence interval (CI): 1.44–2.32; p < 0.01). Inclusion of PCAT attenuation increased the C-index from 0.41 to 0.82 (p = 0.01) and the net reclassification improvement (NRI) by 0.55 (95% CI: 0.34–0.78; p = 0.01). Conclusions: PCAT attenuation was independently associated with the risk of MACEs in post-TAVR patients with obstructive CAD and AS, suggesting the potential utility of PCAT attenuation for risk stratification.